Cultivos de vigilancia epidemiológica de bacterias resistentes a los antimicrobianos de interés nosocomial

ME Cano, C Ezpeleta, B Padilla, ER de Arellano… - … y microbiología clínica, 2008 - Elsevier
Los cultivos de vigilancia epidemiológica y la tipificación molecular han sido importantes
aportaciones de la Microbiología Clínica al control de la infección nosocomial. En este …

[HTML][HTML] Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021

…, ME Portillo, A Navascués, C Ezpeleta… - …, 2021 - eurosurveillance.org
COVID-19 vaccine effectiveness by product (two doses Comirnaty, Spikevax or Vaxzevria
and one of Janssen), against infection ranged from 50% (95% CI: 42 to 57) for Janssen to 86% …

[HTML][HTML] Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021

…, C Burgui, M Guevara, C Ezpeleta… - …, 2021 - eurosurveillance.org
COVID-19 vaccine effectiveness was evaluated in close contacts of cases diagnosed during
January–April 2021. Among 20,961 contacts, 7,240 SARS-CoV-2 infections were confirmed…

Independent role of severe obesity as a risk factor for COVID‐19 hospitalization: a Spanish population‐based cohort study

…, A Navascués, ME Portillo, I Polo, C Ezpeleta… - …, 2021 - Wiley Online Library
Objectives This study analyzed the association between severe obesity and coronavirus
disease 2019 (COVID‐19) hospitalization and severe disease. Methods The incidence of …

[HTML][HTML] Risk factors of infection, hospitalization and death from SARS-CoV-2: a population-based cohort study

…, I Casado, C Burgui, C Ezpeleta… - Journal of Clinical …, 2021 - mdpi.com
We conducted a prospective population-based cohort study to assess risk factors for infection,
hospitalization, and death from SARS-CoV-2. The study comprised the people covered by …

Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain

…, G Trujillo, M Morta, AG Setas, C Ezpeleta… - Journal of Infection, 2016 - Elsevier
Background Most available information on carbapenemase-producing Enterobacteriaceae (CPE)
is usually associated with specific types of infection or patient or with descriptions of …

[HTML][HTML] Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022

…, C Burgui, N Egüés, G Ezpeleta, C Ezpeleta - …, 2022 - eurosurveillance.org
In Navarre, Spain, in May 2022, the seroprevalence of anti-nucleocapsid (N) and anti-spike (S)
antibodies of SARS-CoV-2 was 58.9% and 92.7%, respectively. The incidence of …

[HTML][HTML] Trends and causes of mortality in a population-based cohort of HIV-infected adults in Spain: comparison with the general population

…, Y Floristán, U Fresán, RS Miguel, C Ezpeleta… - Scientific reports, 2020 - nature.com
Combination antiretroviral therapy reduces mortality of HIV-infected persons. In Spain, where
this therapy is widely available, we aim to evaluate mortality trends and causes of death in …

Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001–2013

M Guevara, C Ezpeleta, A Gil-Setas, L Torroba… - Vaccine, 2014 - Elsevier
Pneumococcal conjugate vaccines (PCVs) were licensed for use in children and became
available for private purchase in Spain in 2001 (PCV7), 2009 (PCV10) and 2010 (PCV13). …

Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010‐2016

…, M Fernández‐Alonso, C Ezpeleta… - Influenza and Other …, 2018 - Wiley Online Library
Background Estimating the national burden of influenza disease is challenging. We aimed
to estimate the disease burden of seasonal influenza in Spain, at the primary care and …